Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company is headquartered in Los Angeles, California. The company went IPO on 2024-12-16. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The firm has not commenced any operations. The firm has not generated any revenues.
Oaktree Acquisition III Life Sciences Corp의 주요 재무제표는 무엇인가요?
최신 재무제표(Form-10K)에 따르면, Oaktree Acquisition III Life Sciences Corp의 총 자산은 $0이며, 순손실입니다.
OACC의 주요 재무 비율은 무엇인가요?
Oaktree Acquisition III Life Sciences Corp의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
Oaktree Acquisition III Life Sciences Corp의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Oaktree Acquisition III Life Sciences Corp 주요 수익원은 Service Center Based Distribution이며, 최신 수익 발표에서 수익은 3,014,348,000입니다. 지역별로는 United States이 Oaktree Acquisition III Life Sciences Corp의 주요 시장이며, 수익은 4,000,954,000입니다.
Oaktree Acquisition III Life Sciences Corp은 수익성이 있나요?
no, 최신 재무제표에 따르면 Oaktree Acquisition III Life Sciences Corp의 순손실은 $0입니다.
Oaktree Acquisition III Life Sciences Corp에 부채가 있나요?
no, Oaktree Acquisition III Life Sciences Corp의 부채는 0입니다.
Oaktree Acquisition III Life Sciences Corp의 발행 주식은 몇 주인가요?
Oaktree Acquisition III Life Sciences Corp의 총 발행 주식은 0주입니다.